Bryant Furlow

In our lung cancer quiz, you'll get a chance to test your knowledge of the mortality risk among patients with lung cancer, and learn more about screening criteria to try reduce these rates.

In our multiple myeloma quiz, you'll get a chance to test your knowledge on best practices to treating patients with relapsed/refractory multiple myeloma

In our multiple myeloma quiz, you'll get a chance to test your knowledge on best practices to implement shared decision-making when discussing treatment options with your patients.

In our lung cancer quiz, you'll get a chance to test your knowledge of the management of sarcopenia in patients with lung cancer.

High testosterone and low folate intake together may drastically increase risk of breast cancer.

New guidelines for exercise for patients with cancer have been released.

Multigene testing for all woman diagnosed with breast cancer can be “extremely cost-effective.”

A new analysis found overall survival may be worse for some male breast cancer patients.

A new combination may be key to improving tumor response rates and overall survival in colorectal cancer.

Despite prolonged progression-free duration, a 25% reduction in risk of death associated with anti-androgen agent apalutamide fell short of statistical significance in patients with non-metastatic, high-risk castration-resistant prostate cancer.

African American women are less likely to receive care from leading specialists at Comprehensive Cancer Care centers, but seeking opinions from one can improve outcomes in breast cancer.

Some patients are more likely to find out about their cancer via a visit to the emergency department than others.

How much do you know about stem cell transplantation in multiple myeloma? Here's your chance to find out.

How much do you know about the role of long non-coding RNAs in ovarian cancer? Now is your chance to find out.

How much do you know about the incidence and screening of prostate cancer? Here's your chance to find out.

How much do you know about thrombotic microangiopathies in multiple myeloma? Here's your chance to find out.

How much do you know about the epidemiology and prognosis of ovarian cancer? Here's your chance to find out.

Test your knowledge of metastatic prostate cancer with this month's quiz.

How much do you know about toxicities associated with multiple myeloma? Here's your chance to find out.

How much do you know about predicting patient outcomes in ovarian cancer? Take our latest quiz to test your knowledge.

How much do you know about molecular risk and prognostic biomarkers in prostate cancer? Take our latest quiz to test your knowledge.

How much do you know about the incidence of extramedullary disease in patients with multiple myeloma? Take our latest quiz to test your knowledge.

How much do you know about the link between various germline mutations and ovarian cancer? Take our latest quiz to test your knowledge.

A recent study evaluated whether longstanding assumptions that thin nodular melanomas are less aggressive than thicker ones are accurate.

How much do you know about the use of PET/CT imaging to manage multiple myeloma? Take our latest quiz to test your knowledge.

The study authors evaluated the disease-free survival rate among patients with high-risk primary melanoma and the role of routine sentinel lymph node biopsy.

A new study reported that elderly patients experience a different extent of metastatic disease than do adults diagnosed at younger ages.

How knowledgeable are you about the use of proteasome inhibitors in relapsed/refractory multiple myeloma? Take our latest quiz to find out.

The updates to the guidelines reflect recent advances, including recommended immunotherapies and changes in tumor staging.

The updated version incorporates biologic factors to refine and improve the prognostic stratification of patients with breast cancer.